NaDeNo Gains Access to Nanopharmaceutical Development Services in 2nd Open Call
NaDeNo Nanoscience AS was selected to receive pro bono services to accelerate the development of their nanomedicine.
NaDeNo Nanoscience AS was selected to receive pro bono services to accelerate the development of their nanomedicine.
PHOENIX was present at the Partnership Opportunities in Drug Delivery (PODD) in Boston from 28-29 October 2024.
PHOENIX will be at the ECCPM Forum, which welcomes attendees from diverse pharmaceutical organizations worldwide and features key note lectures…
Want to hear more about PHOENIX services? Join our online introduction to the PHOENIX-OITB services on September 13th!
PHOENIX-OITB gGmbH offers an “all-in-one” Single Entry Point to users, providing manufacturing, characterization, testing and innovation-related consulting services including regulatory…